NDC 0641-6044-01 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6044
- Requested NDC
- 0641-6044-01
- Package NDCs from labels
- 0641-6044-01, 0641-6044-25
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam Injection, USP | REMEDYREPACK INC. | 2024-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam - TYA Pharmaceuticals | TYA Pharmaceuticals | 2011-11-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6044-01 | Lorazepam | 1 mL in 1 VIAL | INJECTION | 1 | 10 | |
| 0641-6044-25 | Lorazepam | 25 in 1 CARTON | INJECTION | 25 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6044-01 | ML - Milliliter | 0641-6044 | 9c10d57c-be4d-4e5c-bd04-680c477d6ef8 | 1 | 2012-07-24 |
| 0641-6044-25 | ML - Milliliter | 0641-6044 | 6e34d5a1-9495-43ce-a1cb-9f6626a83af7 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meijer Multi-Symptom Relief | POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL, ZINC SULFATE | Meijer, Inc. | e7a5677a-ff33-c039-e053-2a95a90ae6c7 | 2025-12-30 | Warnings | B697894SGQ |
| Avenova Lubricant Eye Drops High Performance | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | NovaBay Pharmaceuticals, Inc. | cd17f037-5aa5-0ef8-e053-2a95a90a39cb | 2025-12-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Equate Lubricant Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Walmart, Inc. | deebaf7f-f20d-4d7f-e053-2a95a90a4b4f | 2025-12-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Equate Multi-Symptom Relief Eye Drops | POLYETHYLENE GLYCOL 400,TETRAHYDROZOLINE HCL, ZINC SULFATE | Walmart, Inc. | eb8ed76b-9cd7-3636-e053-2a95a90a9583 | 2025-12-30 | Warnings | B697894SGQ |
| CorneaCare Recover Lubricant Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | CorneaCare Inc. | 1fd3a5ed-8963-5c8e-e063-6394a90a6527 | 2025-12-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Quality Choice Lubricant Eye Drops High Performance | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Chain Drug Marketing Assoc., Inc. | 0cd1b36a-a07a-a1db-e063-6294a90a5994 | 2025-12-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Quality Choice Moisturizing Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Chain Drug Marketing Association, Inc. | 1fb81759-5931-59c8-e063-6294a90a2277 | 2025-12-30 | Warnings | B697894SGQ |
| Quality Choice Lubricant Eye Drops Long Lasting | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Chain Drug Marketing Assoc., Inc. | 0cd91c45-88a2-f88c-e063-6294a90ad127 | 2025-12-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Archies Dry Eye Relief | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Archie's Remedies | 07da099b-6b7f-984d-e063-6294a90a12ac | 2025-12-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Equaline Multi-Symptom Eye Drops | POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL, ZINC SULFATE | United Natural Foods, Inc. | fe467606-6d66-b695-e053-6294a90aab5d | 2025-12-30 | Warnings | B697894SGQ |
| Walgreens Lubricant | POLYETHYLENE GLYCOL 400, AND PROPYLENE GLYCOL | Walgreens | 21dfe061-4538-2061-e063-6394a90a6e73 | 2025-12-19 | Warnings | 6DC9Q167V3 B697894SGQ |
| Artificial Tears | GLYCERIN | Geri-Care Pharmaceuticals, Corp | 7cc437e3-bad9-59be-e053-2991aa0a1da3 | 2025-12-19 | Warnings | B697894SGQ |
| Hepatatox | TRITICUM AESTIVUM, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, GLUTATHIONE, HEPAR SUIS, THYROIDINUM (SUIS), LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, ADRENOCORTICOTROPHIN, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, PHENYL BUTAZONE, PETROLEUM JELLY, PLUMBUM METALLICUM | BioActive Nutritional, Inc | a113a9f1-4792-41a5-8d1b-a6756f356e15 | 2025-12-18 | Warnings | LKG8494WBH |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | B697894SGQ |
| LORAZEPAM | LORAZEPAM | Aurolife Pharma LLC | 5b851f67-309d-4ef3-8b4b-ade8908256ea | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Thermacare Max Strength Lidocaine | THERMACARE MAX STRENGTH LIDOCAINE | Clarion Brands LLC | 44fed887-d1e0-d205-e063-6294a90ac416 | 2025-12-02 | Warnings | LKG8494WBH |
| Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Rollon | THERMACARE HEAT THERAPY MAX STRENGTH LIDOCAINE PAIN RELIEF ROLLON | Clarion Brands LLC | 4482d34d-eaca-5522-e063-6394a90a6afb | 2025-11-26 | Warnings | LKG8494WBH |
| Splash Pure PF | PROPYLENE GLYCOL | LABORATORIOS SOPHIA, S.A. DE C.V. | 40ad7ae5-1f2a-e3b1-e063-6294a90a6f84 | 2025-11-26 | Warnings | 6DC9Q167V3 |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Niagara Pharmaceuticals Inc. | 362a6b6d-862d-4322-87a8-5b3a07fbe174 | 2025-11-24 | Warnings | 6DC9Q167V3 |
| Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel | THERMACARE HEAT THERAPY MAX STRENGTH LIDOCAINE PAIN RELIEF GEL | Clarion Brands LLC | 445db02a-c8e8-6ebb-e063-6294a90a4301 | 2025-11-24 | Warnings | LKG8494WBH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.